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Aim: To present a therapeutic modality of peripartum cardiomyopathy (PPCM). 
Case report: A 24-year-old female patient, with no prior known diagnosis, was admitted to the De-
partment of Cardiology with signs of acute heart failure. A 45 days prior to admission she delivered a 
healthy baby (first pregnancy) via cesarean section, while 20 days before hospitalization she developed 
symptoms like dyspnea, orthopnea, fatigue, weakness and extremely low tolerance to effort. Upon ad-
mission on X-ray, heart shadow was enlarged and, while on electrocardiogram (ECG) there was a sinus 
tachycardia with negative T waves from V1-V5. Echocardiography on admission showed initial dilata-
tion of cardiac chambers, reduced ejection fraction of left ventricle (EFLV; estimated about 25%) with 
global hypokinesia, signs of moderate to severe mitral and tricuspid regurgitation with mild pulmo-
nary hypertension, along with hemodynamically nonsignificant circumferential pericardial effusion 
(diastolic separation of 8mm). Laboratory findings were as follows: NT-pro BNP 1810.0 pg/mL; signs of 
anemia, while inflammatory parameters, cardiac necrosis markers, urea, creatinine, D-dimer and thy-
roid hormones values remained in reference values. Testing for known cardiotropic viruses was not 
positive and PPCM was diagnosed. The patient was treated with cardio selective beta blocker (metopro-
lol), angiotensin-converting enzyme (ACE) inhibitor (ramipril), diuretics (furosemide), spironolactone, 
and digoxin along with supportive therapy. After twelve days of hospital treatment, there was signifi-
cant improvement of the clinical status of our patient. Her symptoms were notably ameliorated. EFLV 
before discharge improved to 40%, heart chambers dimensions were in referral values, while mitral 
and tricuspid regurgitation were significantly reduced into a mild grade, while pericardial effusion was 
also in regression. Follow-up examination after two and six months showed further improvement of 
patients’ conditions while after six months only beta-blocker and acetylsalicylic acid were prescribed 
in therapy. 
Conclusion: PPCM can occur during the end of pregnancy or within five months after delivery with no 
determinable etiology and with absence of cardiac disease in anamnesis.1
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